· 2 min read
Radiation Alters Nuclease Activity in Rat Thymus Cell Nuclei
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer
· 2 min read
By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Based on the PubMed abstract — the full text of this paper was not freely available.
This 1992 study by Seiliev and colleagues, published in Radiation and Environmental Biophysics, looked at enzymes called nucleases, which cut DNA, inside the cell nuclei of rat thymocytes (a type of immune cell) after exposure to radiation.
Using gel electrophoresis, a lab method that separates proteins by size, the researchers identified several nuclease enzymes of different molecular weights: 35, 32, 17.7, 17.2 and 16.4 kilodaltons. The 35 kDa enzyme needed both calcium and magnesium ions to work. After the cells were exposed to 4 Gray of X-irradiation, and after a separate injection of the protein-synthesis blocker cycloheximide, this 35 kDa nuclease activity disappeared. The other four smaller nucleases, which depended only on calcium, became more active starting 60 minutes after irradiation. The authors also report finding these nucleases in a fraction they call polydeoxyribonucleotide, or PDN — short DNA fragments.
This is a basic laboratory study in animal cells, not a human or clinical investigation. It describes enzyme behavior and does not test any therapeutic use of the fragments it detects, nor does it say anything about skin, wound healing or tissue repair.
Our reflection
This paper sits far from today's skincare applications, but it is part of the deep background of PDRN science: understanding how and why cells break DNA down into fragments helped establish the basic biology that later research built on. At Havdis, we find it useful to see how far the field has traveled from this kind of enzymology to today's applied research.
Source
Seiliev AA, Zvonareva NB, Zhivotovsky BD, Hanson KP (1992). Radiation and environmental biophysics.
Read the paper on PubMedDOI: 10.1007/BF01211210
This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.
Related
A 1993 European Journal of Pharmacology study on how defibrotide, a polydeoxyribonucleotide, binds adenosine A1 and A2 receptors in lab experiments.
Read more →1992 Life Sciences study on how defibrotide, a PDRN sodium salt, may fight blood clots via free-radical scavenging and immune cell modulation.
Read more →1992 Thrombosis Research study: defibrotide limited calcium overload and arrhythmia in low-flow perfused rabbit hearts via prostaglandin signaling.
Read more →